Skip to content

ACDcure: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ACDcure

BE 0739.589.762
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€2,673
2024 · -€4,677+€7,350
Equity
-€5,299
2024 · -€7,972+€2,673
Cash
€5,344
2024 · €1,338+€4,006
Balance sheet total
€17,329
2024 · €9,066+€8,263

Largest movements

2024 to 2025
Assets
  • Cash +€4,006

    up €4,006 (+299.4%), from €1,338 to €5,344

    mainly Debts after one year (+€13,880) and Net result for the year (+€2,673)

  • Stocks and contracts +€3,299

    up €3,299 (+74.7%), from €4,415 to €7,715

  • Tangible fixed assets +€1,206

    new in 2025: €1,206

  • Intangible fixed assets -€342

    no longer reported in 2025 (was €342)

Equity and liabilities
  • Debts after one year +€13,880

    new in 2025: €13,880

  • Other debts -€4,249

    down €4,249 (-48.6%), from €8,749 to €4,500

  • Profit (loss) carried forward +€2,673

    up €2,673 (+14.9%), from -€17,972 to -€15,299

  • Trade debts -€1,837

    down €1,837 (-43.3%), from €4,239 to €2,402

  • Accrued charges and deferred income -€1,491

    down €1,491 (-52.2%), from €2,856 to €1,365

Income statement
  • Gross operating margin +€7,504

    up €7,504, from -€2,135 to €5,369

  • Write-downs +€1,120

    new in 2025: €1,120

  • Financial charges -€399

    down €399 (-46.7%), from €853 to €455

  • Other operating charges -€383

    down €383 (-33.5%), from €1,143 to €760

  • Depreciation -€163

    down €163 (-26.7%), from €611 to €448

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€4,677
Gross operating margin +€7,504
Depreciation +€163
Write-downs -€1,120
Other operating charges +€383
Financial income +€20
Financial charges +€399
Result 2025 €2,673

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€8,561
Investment -€1,313
Financing +€13,880
Cash 2024 €1,338
Net result for the year +€2,673
Depreciation +€448
Stocks and contracts -€3,299
Receivables within one year -€93
Trade debts -€1,837
Tax, wage and social debts -€712
Other debts -€4,249
Accrued charges and deferred income -€1,491
Investment in fixed assets (net) -€1,313
Debts after one year +€13,880
Cash 2025 €5,344
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €9,066 €17,329 +€8,263 +91.1%
Fixed assets 21/28 €342 €1,206 +€864 +253.1%
Intangible fixed assets 21 €342 - -€342
Tangible fixed assets 22/27 - €1,206 +€1,206
Plant, machinery and equipment 23 - €1,206 +€1,206
Current assets 29/58 €8,724 €16,123 +€7,399 +84.8%
Stocks and contracts in progress 3 €4,415 €7,715 +€3,299 +74.7%
Stocks 30/36 €4,415 €7,715 +€3,299 +74.7%
Amounts receivable within one year 40/41 €2,971 €3,064 +€93 +3.1%
Trade receivables 40 €2,971 €3,064 +€93 +3.1%
Cash at bank and in hand 54/58 €1,338 €5,344 +€4,006 +299.4%
Total equity and liabilities 10/49 €9,066 €17,329 +€8,263 +91.1%
Equity 10/15 -€7,972 -€5,299 +€2,673 +33.5%
Contributions 10/11 €10,000 €10,000 = 0.0%
Profit (loss) carried forward 14 -€17,972 -€15,299 +€2,673 +14.9%
Amounts payable 17/49 €17,038 €22,628 +€5,590 +32.8%
Amounts payable after more than one year 17 - €13,880 +€13,880
Other amounts payable 178/9 - €13,880 +€13,880
Amounts payable within one year 42/48 €14,182 €7,383 -€6,799 -47.9%
Trade debts 44 €4,239 €2,402 -€1,837 -43.3%
Suppliers 440/4 €4,239 €2,402 -€1,837 -43.3%
Taxes, remuneration and social security 45 €1,193 €481 -€712 -59.7%
Taxes 450/3 €1,193 €481 -€712 -59.7%
Other amounts payable 47/48 €8,749 €4,500 -€4,249 -48.6%
Accrued charges and deferred income 492/3 €2,856 €1,365 -€1,491 -52.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €611 €448 -€163 -26.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €1,120 +€1,120
Other operating charges 640/8 €1,143 €760 -€383 -33.5%
Gross operating margin 9900 -€2,135 €5,369 +€7,504
Operating profit (loss) 9901 -€3,889 €3,041 +€6,931
Financial income 75/76B €65 €86 +€20 +31.3%
Recurring financial income 75 €65 €86 +€20 +31.3%
Financial charges 65/66B €853 €455 -€399 -46.7%
Recurring financial charges 65 €853 €455 -€399 -46.7%
Profit (loss) for the period before taxes 9903 -€4,677 €2,673 +€7,350
Profit (loss) for the period 9904 -€4,677 €2,673 +€7,350
Profit (loss) for the period to be appropriated 9905 -€4,677 €2,673 +€7,350

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.